• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND PK PAPYRUS US 4.0/20; COVERED CORONARY STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND PK PAPYRUS US 4.0/20; COVERED CORONARY STENT Back to Search Results
Model Number 434896
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 09/15/2022
Type of Reportable Event Death
Event or Problem Description
One month before the complaint event on (b)(6) 2022, the patient was successfully treated by stenting in the medial lcx.At the event date, due to chest pain, the patient underwent a diagnostic angiography to prepare an rca stenting.During the diagnostic angiography a type iii cs/iv perforation in the lm occurred with a large pericardial effusion and the patient became unstable.A pericardial drain was placed, and a significant amount of blood was evacuated from the pericardial space.An emergency sternotomy was performed.The alleged perforation was identified in the ostial to proximal lad.To stop the bleeding a vein graft was implanted to graft the lad.After additional angiographies, it was noted that the actual perforation is not in the lad but in the lm.The complaint stent was chosen and implanted across the perforation in the lm and post dilated, but the bleeding situation could not be stopped.The situation has worsened more, as the tear was now near the lm ostium and it was planned to replace the aortic root.During the preparation for that, a significant venous bleeding in the abdomen was noticed.The situation was agreed not to be a salvageable situation and after discussion with the family it was decided to withdraw the support systems and the patient died.In the death summary, it was stated that the patients tissues seemed to be very friable.It was clarified that there is a family history of connective tissue disease.The information provided in the pk papyrus device registration form stated that there was no device-related complication but a procedure-related complication from the diagnostic angiography.(b)(4).
 
Additional Manufacturer Narrative
The affected pk papyrus stent system was not returned to biotronik and could therefore not be subjected to a technical investigation.Images of the case such as angiographies could also not be obtained.Review of the product release documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections during which a 100 percent control of the stent cover is performed.Based on the provided documentation and the conducted review no device deficiency or manufacturing related root cause for the reported potentially insufficient sealing of the perforation could be identified.The information provided in the pk papyrus device registration form stated that there was no device or procedure-related complication.The physician stated that the patients tissue seemed to be very friable and that there is a family history of connective tissue disease which might have been a contributing factor for the complaint event.Pk papyrus is indicated for the treatment of acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 mm in diameter.As such, this device is typically used in emergent response to a life-threatening adverse procedural event unrelated to use of the pk papyrus.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PK PAPYRUS US 4.0/20
Common Device Name
COVERED CORONARY STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key15529794
Report Number1028232-2022-05073
Device Sequence Number16770808
Product Code NIV
UDI-Device Identifier07640130447240
UDI-Public(01)07640130447240(17)2302
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
H170004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 09/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2023
Device Model Number434896
Device Catalogue NumberSEE MODEL NO.
Device Lot Number02214099
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/22/2022
Initial Report FDA Received Date10/03/2022
Date Device Manufactured03/26/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age50 YR
Patient SexMale
-
-